Business & Industry
Business & Industry
Sobi to Get Rights to Pozdeutinurad – Oral URAT1 Inhibitor
For a $950 million upfront, Sobi is all set to get rights to pozdeutinurad - oral URAT1 inhibitor that performed pretty well in the Phase II studies.
Sobi is taking over Arthrosi Therapeutics, which is California-based, in a move to...
Business & Industry
BaseLaunch to Benefit from Biotech Innovation of Takeda
In one of the most prominent developments for the biotech sector, BaseLaunch has officially welcomed Takeda as its new pharmaceutical partner. This collaboration is going to enhance the present partnership with five other leading pharma companies, now totaling six....
Business & Industry
EU Pharmaceutical Legislation to be Reformed After 2 Decades
The European Council and European Parliament reached a provisional political agreement, on a comprehensive overhaul of the EU pharmaceutical legislation, the first major reform in more than two decades. The agreement establishes a modernized regulatory framework designed to balance...
BioPharma
Successful Lab Design: Teams, Communication and Expertise
When we state that lab space happens to be a really exciting possibility, people don't find it surprising. Unfortunately, most laboratories don't have many possibilities to build the kind of place that continues to improve the technological aspect, resolve...
BioPharma
Lab Efficiency And Safety Through Smart Inventory Control
Inventory management is the work that laboratorians do on a daily basis that is both the most important and the most loathed. This is because inventory management is both the most essential and the most disliked duty. However, ineffective...
BioPharma
Bringing Seamlessness to the Pharmaceutical Supply Chain
It is well to be noted that freight audits, in addition to payment partnerships, go ahead and optimize the pharmaceutical supply chain in a very significant manner through elevating growth and at the same time giving push to innovation.
The...
BioPharma
IQVIA Agentic AI Platform Builds New Capabilities with AWS
IQVIA, known across the life sciences industry for its clinical research operations, commercial analytics, and health-data expertise, has entered a strategic collaboration with Amazon Web Services (AWS), naming AWS as its Preferred Agentic Cloud Provider. Announced during AWS re:Invent,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















